Search
for
Sort by
Research 31–60 of 326
- Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19)
- Cutaneous manifestations of COVID-19
- Severe cutaneous adverse reactions to drugs
- Pustular allergic contact dermatitis caused by fragrances
- COVID-19 infection leading to acute pustular dermatoses
- Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report
- Etoricoxib
- SDRIFE Induced by Tofacitinib
- Presentation and Management of Cutaneous Manifestations of COVID-19
- 345. Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico
- Ichthyosiform Erythroderma, a Multifaceted Syndromic Entity
- An autopsy case of unicentric Castleman's disease associated with bronchiolitis obliterans
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- TOC
- Skin and hair disorders
- Adverse Cutaneous Reactions to Antipsychotics
- Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico
- Anticonvulsant-Induced Cutaneous Reactions
- Psychoactive drugs and skin
- Transient heart failure in an adult with kawasaki disease
- COVID‐19 dermatological manifestations: results from the Mexican Academy of Dermatology COVID‐19 registry
- KERION MICROSPORICUM WITH HEMATOGENOUS AND ECTOGENOUS MICROSPORIDS
- 603 Degradation of aberrant NETs by DNases is a promising therapeutic strategy for SJS/TEN
- Cutaneous Drug Reaction Case Reports
- Cirmcumscribed juvenile pityriasis rubra pilaris in a 5-year-old-girl treated with topical keratolytic and steroid
- Finasteride
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Kawasaki disease: an update
- Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options